Clinical Trial Update: PowerAssert Radio-Frequency (RF) Guidewire Coronary In-Stent Chronic Total Occlusion (CTO) [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the PowerAssert RF guidewire for coronary in-stent chronic total occlusion has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Snippet

Sponsor: Stereotaxis | Conditions: Coronary Artery Disease | Phase 2 | Status: COMPLETED